DexCom
DXCM
#580
Rank
HK$269.99 B
Marketcap
HK$691.25
Share price
1.51%
Change (1 day)
-27.10%
Change (1 year)

P/E ratio for DexCom (DXCM)

P/E ratio as of February 2025 (TTM): 90.6

According to DexCom's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 90.5918. At the end of 2022 the company had a P/E ratio of 129.

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022129-49.43%
2021254258.6%
202071.0-64.64%
2019201-341.22%
2018-83.2-14.47%
2017-97.327.09%
2016-76.5-31.78%
2015-112-38.86%
2014-184117.65%
2013-84.3390.1%
2012-17.225.65%
2011-13.7-0.7%
2010-13.8105.02%
2009-6.73387.32%
2008-1.38-74.68%
2007-5.45-5.47%
2006-5.7731.79%
2005-4.38

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
30.7-66.13%๐Ÿ‡บ๐Ÿ‡ธ USA
44.2-51.26%๐Ÿ‡บ๐Ÿ‡ธ USA
44.6-50.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-11.4-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
33.7-62.79%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
44.4-50.95%๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-87.88%๐Ÿ‡บ๐Ÿ‡ธ USA
220 142.68%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.